Biogaia AB
STO:BIOG B
Biogaia AB
STO:BIOG B
Price:
113.6 SEK
-0.44%
Market Closed
Updated:
May 7, 2024
Biogaia AB
Cash from Financing Activities
|
Biogaia AB
Cash from Financing Activities Peer Comparison
Comparables:
BONEX
VITR
PROB
SOBI
BIOA B
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biogaia AB
STO:BIOG B
|
Cash from Financing Activities
-kr308.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Cash from Financing Activities
-kr6.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Cash from Financing Activities
-kr300m
|
CAGR 3-Years
-125%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-19%
|
|
|
Probi AB
STO:PROB
|
Cash from Financing Activities
-kr24m
|
CAGR 3-Years
5%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-13%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Cash from Financing Activities
kr17B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
55%
|
|
|
BioArctic AB
STO:BIOA B
|
Cash from Financing Activities
kr14.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biogaia AB's Cash from Financing Activities?
Cash from Financing Activities
-308.4m
SEK
-308.4m
SEK
Based on the financial report for Dec 31, 2023, Biogaia AB's Cash from Financing Activities amounts to -308.4m SEK.
What is Biogaia AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-14%
-14%
Over the last year, the Cash from Financing Activities growth was 2%.
You don't have any saved screeners yet
